Prediktivna vrednost izuzetno niskih nivoa PAPP-A, slobodnog βhCG i izuzetno visokog srednjeg pulzatornog indeksa uterinih arterija u prvom trimestru trudnoće u proceni nastanka intrauterusnog zastoja u rastu ploda

  • Relja Lukić University of Belgrade, Faculty of Medicine, Clinic for Gynecology and Obstetric „Narodni Front“, Belgrade, Serbia
  • Nataša Karadžov-Orlić University of Belgrade, Faculty of Medicine, Clinic for Gynecology and Obstetric „Narodni Front“, Belgrade, Serbia
  • Amira Egić University of Belgrade, Faculty of Medicine, Clinic for Gynecology and Obstetric „Narodni Front“, Belgrade, Serbia
  • Barbara Damnjanović-Pažin University of Belgrade, Faculty of Medicine, Clinic for Gynecology and Obstetric „Narodni Front“, Belgrade, Serbia
  • Željko Miković University of Belgrade, Faculty of Medicine, Clinic for Gynecology and Obstetric „Narodni Front“, Belgrade, Serbia
Ključne reči: trudnoća, prvi trimestar, fetus, zaostajanje u rastu, ultrasonografija, dopler kolor, plazma, protein a, udružen sa trudnoćom, horionski gonadotropin, beta subjedinica, humani

Sažetak


Uvod/Cilj. Neželjeni ishodi trudnoće kao što su pre­ek­lampsija, abrupcija placente i zaostajanje rasta fetusa i mrtvorođenost mogu biti prepoznati u okvirima pre­natalnog skrininga. Cilj ove studije bio je ispitati mogućnost predviđanja pojave intrauterusnog zastoja u rastu ploda (IUGR) pojedinačnom i kombinovanom upotrebom izu­zetno niskih vrednosti plazma proteina A povezanog sa trudnoćom (PAPP-A), izuzetno niskih vrednosti slobodne beta subjedinice humanog horionskog gonadotropina (free βhCG), kao i ekstremno visokih srednjih vrednosti dop­lerskog pulsatilnog indeksa (PI) uterinih arterija u prvom trimestru trudnoće. Metode. Prospektivnom studijom analizirane su jednoplodne trudnoće starosti 11–13+6 nedelja gestacije u okviru rutinskog skrininga na Daunov sindrom. Studija je rađena na Odeljenju za visoko rizične trudnoće, univerzitetske Ginekološko-akušerske klinike „Narodni front“ u Beogradu, Srbija. Skrining prvog trimestra je obuhvatao analizu: PAPP-A, free βhCG i PI kod normotenzivnih nulipara, kod kojih su zabeležene ekstremno niske vrednosti PAPP-A (PAPP-A ≤ 0,52 unit multiple of median – MoM) i/ili ekstremno niske vrednosti free βhCG (free βhCG ≤ 0,56 MoM) i/ili ekstremno visoke vrednosti PI (PI ≥ 2,52). Resultati. Kod 85 trudnica uključenih u konačnu analizu, kod njih 14 (16,5 %) je zabeležena pojava IUGR ploda. PAPP-A ≤ 0,52 MoM i PI ≥ 2,52, kao pojedinačne kategorijske varijable, su prepoznate kao varijable sa visokim prediktivnim značajem za pojavu IUGR (odds ratio – OR = 3,064, 95% confidence interval – CI = 0,634 – 14,810, p = 0,046 i OR = 2,129, 95% CI = 0,449 – 10,713, p = 0,021). Daljom analizom, receiver operating characteristic (ROC) – kriva je identifikovala PAPP-A i PI, kao kontinualne varijable, koje su značajni prediktori za pojavu IUGR ploda (area under the curve – AUC = 0,671, 95% CI = 0,521 – 0,820, p = 0,045 i AUC = 0,744, 95% CI = 0,587 – 0,902, p = 0,004). Zaključak. Ova studija sugeriše da u prvom trimestru trudnoće ekstremno niske vrednosti PAPP-A i ekstremno visoke srednje vrednosti Doppler-PI uterinih arterija mogu biti značajni parametri za predviđanje pojave IUGR ploda. Opisani model bi mogao da se primeni u svakodnevnoj kliničkoj praksi u zemljama sa ograničenim mogućnostima, kada ostali parametri za predviđanje pojave IUGR ploda nisu dostupni.

Reference

Hossain N, Paidas MJ. Adverse pregnancy outcome, the uteroplacental interface and preventive strategies. Semin Perinatol 2007; 31(4): 208–12.

Frøen JF, Cacciatore J, McClure EM, Kuti O, Jokhio AH, Islam M, et al.Lancet’s Stillbirths Series Steering Committee: Stillbirths: why they matter. Lancet 2011; 377(9774): 1353–66.

Brosens I, Pijnenborg R, Vercruysse L, Romero R. The “Great Obstetrical Syndrome” are associated with disorders of deep placentation. Am J Obstet Gynecol 2011; 204(3): 193–201.

Cnattingius S, Stephansson O. The challenges of reducing risk factorsfor stillbirths. Lancet 2012; 377(9774): 1294–5.

Costa SL, Proctor L, Dodd JM, Toal M, Okun N, Johnson JA, et al. Screening for placental insufficiency in high-risk pregnancies: is earlier better? Placenta 2008; 29(12): 1034–40.

Tikkanen M. Etiology, clinical manifestations and prediction of placental abruption. Acta Obstet Gynecol Scand 2010; 89(6): 732–40.

Poon LC, Volpe N, Muto B, Yu CK, Syngelaki A, Nicolaides KH. Second-Trimester Uterine Artery Doppler in the Prediction of Stillbirths. Fetal Diagn Ther 2013; 33(1): 28–35.

Sarmiento A, Casasbuenas A, Rodriguez N, Angarita AM, Sarmiento P, Sepulveda W. First-trimester uterine artery Doppler velocimetry in the prediction of birth weight in a low-risk population. Prenat Diagn 2013; 33(1): 21–4.

Borrell A, Grande M, Bennasar M, Borobio V, Jimenez JM, Stergiotou I, et al. First-trimester detection of major cardiac defects with the use of ductus venosus blood flow. Ultrasound Obstet Gynecol 2013; 42(1): 51–7.

Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br J Obstet Gynecol 2003; 107(10): 1271–5.

Karadzov-Orlic N, Egic A, Milovanovic Z, Marinkovic M, Damnjanovic-Pazin B, Lukic R, et al. Improved diagnostic accuracy by using secondary ultrasound markers in the first-trimester screening for trisomies 21, 18 and 13 and Turner syndrome. Prenat Diagn 2012; 32(7): 638–43.

Poon LC, Nicolaides KH. First-trimester maternal factors andbiomarker screening for preeclampsia. Prenat Diagn 2014; 34(7): 618–27.

Goetzinger KR, Singla A, Gerkowicz S, Dicke JM, Gray DL, Odibo AO. Predicting the risk of pre-eclampsia between 11 and 13 weeks’ gestation by combining maternal characteristics and serum analytes, PAPP-A and free β-hCG. Prenat Diagn 2010; 30(12–13): 1138–42.

Poon LC, Staboulidou I, Maiz N, Plasencia W, Nicolaides KH. Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks. Ultrasound Obstet Gynecol 2009; 34(2): 142–8.

Resnik R. Intrauterine growth restriction. Obstet Gynecol 2002; 99(3): 490–6.

Pilalis A, Souka AP, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks’ gestation. Ultrasound Obstet Gynecol 2007; 29(2): 135–40.

Wright D, Akolekar R, Syngelaki A, Poon LC, Nicolaides KH. A competing risks model in early screening for preeclampsia. Fetal Diagn Ther 2012; 32(3): 171–8.

Irwin JC, Suen LF, Martina N, Mark SP, Giudice LC. Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum Reprod 1999; 14 Suppl 2: 90–6.

Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al.First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004, 191(4): 1446–51.

Karagiannis G, Akolekar R, Sarquis R, Wright D, Nicolaides KH. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks. Fetal Diagn Ther 2011; 29(2): 148–54.

Kirkegaard I, Uldbjerg N, Henriksen TB. PAPP-A and free ß HCG in relation to admission to neonatal invasive care unit and neonatal disease. Prenat Diagn 2011; 31(12): 1169–75.

Martin AM, Bindra R,Curcio P, Cicero, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18(6): 583–6.

Parra M, Rodrigo R, Barja P, Bosco C, Fernández V, Muñoz H, et al. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005; 193(4): 1486–91.

Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirinstarted in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116(2 Pt 1): 402–14.

Cruz-Lemini M, Crispi F, Van Mieghem T, Pedraza D, Cruz-Martínez R, Acosta-Rojas R, et al. Risk of perinatal death in early-onset intrauterine growth restriction according to gestational age and cardiovascular Doppler indices: a multicenter study. Fetal Diagn Ther 2012; 32(1–2): 116–22.

Objavljeno
2021/08/04
Rubrika
Originalni članak